Literature DB >> 9832428

Interaction of insulin receptor substrate-1 (IRS-1) with phosphatidylinositol 3-kinase: effect of substitution of serine for alanine in potential IRS-1 serine phosphorylation sites.

L Delahaye1, I Mothe-Satney, M G Myers, M F White, E Van Obberghen.   

Abstract

Serine and threonine phosphorylation has been shown to down-regulate insulin signaling at multiple steps, including the receptor and downstream molecules such as insulin receptor substrate-1 (IRS-1). To further address the mechanism of this regulation at the level of IRS-1, we constructed a double serine mutant of IRS-1: S662A/S731A-IRS-1. The serines 662 and 731 mutated to alanine are surrounding tyrosines Y658 and Y727, respectively. These tyrosines are comprised in YXXM motifs, which are potential binding sites for the p85alpha regulatory subunit of phosphatidylinositol (PI) 3-kinase. In a first series of experiments using the yeast two-hybrid system, we show that IRS-1 interacts with p85alpha, and this interaction depends on tyrosine phosphorylation, as shown with the IRS-1 mutant F18 and 3Y-IRS-1. F18-IRS-1 contains 18 potential tyrosine phosphorylation sites mutated to phenylalanine; three of them, i.e. Y608, 628, and 658, which are potential binding sites for p85alpha, have been added back in the 3Y-IRS-1 mutant. The tyrosine phosphorylation of IRS-1, which is required for the interaction with p85alpha, is thought to occur via endogenous yeast kinases that phosphorylate IRS-1 at least on these PI 3-kinase-binding sites. Next, we show that not only p85alpha but also p55PIK, another regulatory subunit of PI 3-kinase, interacts with IRS-1 in yeast. Interestingly, for both regulatory subunits their interaction with IRS-1 is up-regulated by mutating serines 662 and 731 on IRS-1. In a previous study we found that insulin-stimulated PI 3-kinase activity was increased not only in the presence of S662A/S731A-IRS-1 but also under resting conditions compared with the activity seen with WT-IRS-1. Here we demonstrate in 293-EBNA cells overexpressing S662A/S731A-IRS-1 that insulin-stimulated protein kinase B activity is not augmented, whereas without insulin treatment, basal activity is increased compared with that in cells overexpressing wild-type IRS-1. In conclusion, we have shown that 1) potential serine phosphorylation sites on IRS-1, which are adjacent to YXXM binding motifs for PI 3-kinase, negatively regulate binding of IRS-1 to PI 3-kinase regulatory subunits; and 2) these modulations affect protein kinase B activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832428     DOI: 10.1210/endo.139.12.6379

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  Cellular compartmentalization in insulin action: altered signaling by a lipid-modified IRS-1.

Authors:  K M Kriauciunas; M G Myers; C R Kahn
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Loss of inhibitory insulin receptor substrate-1 phosphorylation is an early event in mammalian target of rapamycin-dependent endometrial hyperplasia and carcinoma.

Authors:  Adrienne S McCampbell; Heather A Harris; Judy S Crabtree; Richard C Winneker; Cheryl L Walker; Russell R Broaddus
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-23

3.  Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.

Authors:  JinXiang Dai; Kathryn K Bercury; Wendy B Macklin
Journal:  Glia       Date:  2014-07-25       Impact factor: 7.452

4.  Implication of low level inflammation in the insulin resistance of adipose tissue at late pregnancy.

Authors:  J de Castro; J Sevillano; J Marciniak; R Rodriguez; C González-Martín; M Viana; O H Eun-suk; S Hauguel de Mouzon; E Herrera; M P Ramos
Journal:  Endocrinology       Date:  2011-09-13       Impact factor: 4.736

5.  Characterization of the Met326Ile variant of phosphatidylinositol 3-kinase p85alpha.

Authors:  Katrine Almind; Laurent Delahaye; Torben Hansen; Emmanuel Van Obberghen; Oluf Pedersen; C Ronald Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-12       Impact factor: 11.205

6.  Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.

Authors:  Guoqiang Jiang; Qing Dallas-Yang; Subarna Biswas; Zhihua Li; Bei B Zhang
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

7.  Morphine induces desensitization of insulin receptor signaling.

Authors:  Yu Li; Shoshana Eitan; Jiong Wu; Christopher J Evans; Brigitte Kieffer; Xiaojian Sun; Roberto D Polakiewicz
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

8.  Chronic 17beta-estradiol treatment improves skeletal muscle insulin signaling pathway components in insulin resistance associated with aging.

Authors:  M Moreno; P Ordoñez; A Alonso; F Díaz; J Tolivia; C González
Journal:  Age (Dordr)       Date:  2009-05-22

9.  Expression and function of the insulin receptor substrate proteins in cancer.

Authors:  Katerina Mardilovich; Shannon L Pankratz; Leslie M Shaw
Journal:  Cell Commun Signal       Date:  2009-06-17       Impact factor: 5.712

10.  PI3-kinase mutation linked to insulin and growth factor resistance in vivo.

Authors:  Jonathon N Winnay; Marie H Solheim; Ercument Dirice; Masaji Sakaguchi; Hye-Lim Noh; Hee Joon Kang; Hirokazu Takahashi; Kishan K Chudasama; Jason K Kim; Anders Molven; C Ronald Kahn; Pål R Njølstad
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.